文献速递糖尿病

四跨膜蛋白7胞质末端携带1型糖尿病自身抗体识别的表位

Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes.
PubMed 文献 · Diabetologia · 2019-02-21

该研究旨在鉴定四跨膜蛋白7(TSPAN7)自身抗体识别的表位区域及关键氨基酸残基。通过用TSPAN7抗体阳性血清免疫沉淀荧光素酶标记的单个或多个TSPAN7结构域,再通过单氨基酸突变鉴定结合关键残基。结果显示抗体结合最常见于含NH2端胞质域1(C1;高达39%)或COOH端C3(高达22%)的TSPAN7蛋白,C3结合关键残基为Y246、E247和R239,未观察到对外部结构域的结合。

要点

  • TSPAN7自身抗体主要识别胞质域C1(高达39%)和C3(高达22%)。
  • C3域结合依赖构象,关键残基为Y246、E247和R239。
  • 未观察到对TSPAN7外部结构域的抗体结合。

核心结论

  • TSPAN7自身抗体主要结合胞质末端C1和C3域,C3域结合依赖构象,关键残基为Y246、E247和R239。

研究设计与样本

  • 用TSPAN7抗体阳性血清免疫沉淀荧光素酶标记的单个或多个TSPAN7结构域以鉴定表位区域,再通过单氨基酸突变鉴定关键残基。

主要发现

  • 抗体结合最常见于含C1域的TSPAN7蛋白(高达39%)或含C3域的蛋白(高达22%)。
  • C3域与侧翼跨膜域共表达时结合更频繁,提示构象重要。
  • 未观察到对外部结构域的结合。
  • C3域单氨基酸突变鉴定Y246、E247和R239分别为9/10、10/10和8/10血清结合的关键残基。
  • C235或C236突变导致部分血清结合下降(分别8/178和15/178,>2倍下降)或上升(分别30/178和13/178,>2倍上升)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The beta cell protein tetraspanin 7 is a target of autoantibodies in individuals with type 1 diabetes. The aim of this study was to identify autoantibody epitope-containing regions and key residues for autoantibody binding. METHODS: Autoantibody epitope regions were identified by immunoprecipitation of luciferase-tagged single or multiple tetraspanin 7 domains using tetraspanin 7 antibody-positive sera. Subsequently, amino acids (AAs) relevant for autoantibody binding were identified by single AA mutations. RESULTS: In tetraspanin 7 antibody-positive sera, antibody binding was most frequent to tetraspanin 7 proteins that contained the NH2-terminal cytoplasmic domain 1 (C1; up to 39%) or COOH-terminal C3 (up to 22%). Binding to C3 was more frequent when the domain was expressed along with the flanking transmembrane domain, suggesting that conformation is likely to be important. Binding to external domains was not observed. Single AA mutations of C3 identified residues Y246, E247 and R239 as critical for COOH-terminal binding of 9/10, 10/10 and 8/10 sera tested, respectively. Mutation of cysteines adjacent to the transmembrane domain at either residues C235 or C236 resulted in both decreased (8/178 and 15/178 individuals, respectively; >twofold decrease) and increased (30/178 and 13/178 individuals, respectively; >twofold increase) binding in participant sera vs wild-type protein. CONCLUSIONS/INTERPRETATION: We hypothesise that conformation and, potentially, modification of protein terminal ends of tetraspanin 7 may be important for autoantibody binding in type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Eugster A, Kraus G, Lidzba V, et al. Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes. Diabetologia. 2019. PMID: 30789994. doi:10.1007/s00125-019-4832-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。